跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
QCIN CAPSULE 150 MG - HSA Drug Approval Details
Approvals
/
HSA
/
QCIN CAPSULE 150 MG
Approved
THERAPEUTIC
QCIN CAPSULE 150 MG
RENATA LIMITED
🇸🇬 Health Sciences Authority
Approval Date
Jul 18, 2024
Approval ID
585d2eb9e1e60f8c
Company
RENATA LIMITED
Type
Therapeutic
Approval Details
Approval Id
585d2eb9e1e60f8c
Drug Name
QCIN CAPSULE 150 MG
Product Name
QCIN CAPSULE 150 MG
Approval Number
SIN17046P
Approval Date
2024-07-18
Registrant
SEA PHARMA CONSULTANCY PTE LTD
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
CAPSULE
Route Of Administration
ORAL
Atc Code
J01FF01
Pharma Manufacturer Name
SEA PHARMA CONSULTANCY PTE. LTD.
Company Detail Path
/organization/sea-pharma-consultancy-pte-ltd
Active Ingredients
Clindamycin Hydrochloride eqv Clindamycin
150 mg
Clindamycin Hydrochloride eqv Clindamycin
150 mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jul 18, 2024
Approval ID
585d2eb9e1e60f8c
Type
Therapeutic
Back to HSA Approvals